Q4 2019 Earnings Presentation
2.20.20
Q4 2019 Earnings Presentation 2.20.20 Safe HarborStatement Safe - - PowerPoint PPT Presentation
Q4 2019 Earnings Presentation 2.20.20 Safe HarborStatement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this presentation are forward-looking statements. In some cases, you can identify
2.20.20
Safe HarborStatement
2
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this presentation are forward-looking
“intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” the negative of these terms and other comparable
actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including a decline in the growth in demand for electric vehicles; adverse global economic conditions; the success of Livent’s research and development efforts; volatility in the price for performance lithium compounds; risks relating to Livent’s planned production expansion and related capital expenditures; reduced customer demand, or delays in growth of customer demand, for higher performance lithium compounds, the potential development and adoption of battery technologies that do not rely on performance lithium compounds as an input; risks inherent in international operations and sales, including political, financial and operational risks specific to Argentina, China and other countries where Livent has active operations; customer concentration and the possible loss of, or significant reduction in orders from, large customers; failure to satisfy customer quality standards; fluctuations in the price of energy and certain raw materials; failure to achieve the expected benefits of Livent’s separation from FMC as well as the other factors described under the caption entitled “Risk Factors” in Livent’s 2018 Form 10-K filed with the Securities and Exchange Commission on February 28, 2019, and subsequent Forms 10-Q filed with the Securities and Exchange Commission. Although Livent believes the expectations reflected in the forward-looking statements are reasonable, Livent cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking
statements to actual results or revisedexpectations.
Non-GAAP FinancialTerms
In these slides, Livent uses the financial measures adjusted earnings per diluted share, Adjusted EBITDA, and adjusted cash from operations. These terms are not calculated in accordance with generally accepted accounting principles (GAAP). Livent has posted supplemental information
calculated and presented in accordance with GAAP. Although we provide forecasts for adjusted earnings per diluted share, Adjusted EBITDA, and adjusted cash from operations, we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast such GAAP measures or to reconcile corresponding non-GAAP financial measures to such GAAP measures without unreasonable efforts. For the same reason, we are unable to address the probable significance of the unavailable information. Such elements include, but are not limited to, restructuring, transaction related charges, and related cash activity. As a result, no GAAP outlook is provided.
3
Highlights
4
Current Market Conditions
Q4 2019 Q3 2019 Q4 vs. Q3 2019 2018 2019 vs. 2018
Revenue $78 $98 (20%) $388 $443 (12%) GAAP Net Income $0 $18 (100%) $50 $127 (60%) Adjusted EBITDA (1) $16 $28 (43%) $100 $183 (45%) GAAP EPS 0¢ 12¢ (100%) 34¢ 99¢ NM Adjusted EPS (1) 5¢ 12¢ (58%) 42¢ 91¢ (54%)
Q4 Full Year
Reported Financial Results
5
Note: Amounts in millions of USD, except earnings per diluted share. (1) Denotes non-GAAP financial term. (2) Assumes 127.7 million weighted average shares outstanding for 2018. For the portion of 2018 prior to our initial public offering, the weighted average shares outstanding were calculated using 123.0 million shares, which was the number of shares issued to FMC in part in exchange for the asset contribution by FMC to us (excludes 23.0 million shares of common stock subsequently issued as part of the public offering).
(2) (2)Full Year 2020 Outlook
6
Note: Amounts in millions of USD, except adjusted earnings per diluted share. (1) Denotes non-GAAP financial term. (2) Adjusted EPS calculated using approximately 146.7 million weighted average diluted shares outstanding.
Full Year 2019A Full Year 2020E Revenue $388 $375 - $425 Adjusted EBITDA (1) $100 $60 - $85 Adjusted EPS (1)(2) 42¢ 18¢ - 31¢
Full Year 2020 Outlook (cont’d)
7
~30% increase at midpoint
(000 LCE tons)
2019 2020E Hydroxide / Carbonate (1) ~17.0 22.5 - 24.5 Other LCEs (2) ~4.0 ~4.0 Total LCEs ~21.0 26.5 - 28.5
(1) 1 LCE ton is equivalent to c.1.1 product tons of hydroxide. (2) Other LCEs includes Butyllithium, High Purity Lithium Metal and Other Specialty Compounds.
Driver EBITDA Impact Commentary / Expectations Volume Increase Third-Party Carbonate Costs Decrease Price / Mix Decrease Cost & Other Flat to Slight Decrease
Full Year 2020 Outlook Compared to 2019
8
mid-teens percent lower
party carbonate
Cash Flow and Capital Spending
9
Note: Amounts in millions of USD; numbers may not tie due to rounding. (1) Denotes non-GAAP financial term. (2) Includes capital expenditures and other investing activities.
Full Year Outlook 2019 2018 '19 vs. '18 2020 Cash From Operations (GAAP) $58 $92 ($34) Adjusted Cash from Operations (1) $90 $101 ($11) $75 - $95 Capital Spending (1)(2) ($189) ($78) ($110) ($200) - ($230) Of which: Growth ($153) ($46) ($107) (~$185) Maintenance ($36) ($32) ($4) (~$30)
10
Capacity Expansion Update
Lithium Carbonate (Argentina)
Complete In Progress In Progress Commence H2 2020 N/A 2020 H2 2020 Early 2021 Mid-2021 Lithium Hydroxide (U.S.)
In Progress Commence Early 2021 H2 2020 Early 2021 Mid-2021
Status Expected Completion
11
Market Outlook
$183 $100 ($2) ($39) ($39) ($4) Adj. EBITDA 2018 Volume Price / Mix Cost & Other F/X Adj. EBITDA 2019 $28 $16 ($9) $1 ($3) ($1) Adj. EBITDA Q3 2019 Volume Price / Mix Cost & Other F/X Adj. EBITDA Q4 2019
Q4 and Full Year 2019 Financial Bridges
13
Note: Amounts in millions of USD; numbers may not tie due to rounding; (1) Denotes non-GAAP financial term.
Q4 2019 vs. Q3 2019 FY 2019 vs. FY 2018
(1) (1)$443 $388 ($11) ($39) ($4) Revenue 2018 Volume Price / Mix F/X Revenue 2019
(1) (1)$98 $78 ($20) $1 ($0) Revenue Q3 2019 Volume Price / Mix F/X Revenue Q4 2019